Skip to content

An Observational Study to Investigate the Effects of Rapid Transmeridian Travel

An Observational Study to Investigate the Effects of Rapid Travel

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02560103
Enrollment
119
Registered
2015-09-25
Start date
2015-09-30
Completion date
2017-10-31
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jet Lag Disorder

Brief summary

Observational study to investigate circadian rhythm patterns

Interventions

OTHERTransmeridian travel across multiple time zones

Sponsors

Vanda Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability and acceptance to provide written consent * Men or women between 18-75 years * Body Mass Index of ≥ 18 and ≤ 30 kg/m2

Exclusion criteria

* History (within the 12 months prior to screening) of psychiatric disorders * Major surgery, trauma, illness or immobile for 3 or more days within the past month * Pregnancy or recent pregnancy (within 6 weeks) * A positive test for drugs of abuse at the screening visit * Any other sound medical reason as determined by the clinical investigator

Design outcomes

Primary

MeasureTime frame
Effects of transmeridian travel on nighttime sleep after transmeridian travel measured by Polysomnography (PSG)4 days
Karolinska Sleepiness Scale (KSS) in subjects who experienced rapid transmeridian travel.4 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026